Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8761 | 1151 | 35.2 | 79% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1620 | 6498 | PNEUMOCYSTIS CARINII//PNEUMOCYSTIS JIROVECII//PNEUMOCYSTIS CARINII PNEUMONIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BACTERIAL PNEUMONIA | Author keyword | 4 | 14% | 2% | 24 |
2 | MALAWI LIVERPOOL WELLCOME PROGRAMME CLIN TROP | Address | 3 | 60% | 0% | 3 |
3 | DPUO | Address | 3 | 32% | 1% | 7 |
4 | UNIT IMMUNE INFECT DIS | Address | 2 | 40% | 0% | 4 |
5 | HIV INFECTED CHILDREN | Author keyword | 2 | 16% | 1% | 11 |
6 | DOUBLE NEGATIVE B CELLS | Author keyword | 1 | 100% | 0% | 2 |
7 | HIV INFECTED ADULTS | Author keyword | 1 | 50% | 0% | 2 |
8 | OSPED CIVILE NUOVO | Address | 1 | 100% | 0% | 2 |
9 | PATHOL IMMUNOL PAEDIAT | Address | 1 | 100% | 0% | 2 |
10 | PNEUMOCOCCAL POLYSACCHARIDE VACCINE | Author keyword | 1 | 11% | 1% | 10 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LYMPHOCYTE DYSFUNCTIONS | 22 | 81% | 1% | 13 |
2 | IMPAIRED RESPONSE | 20 | 63% | 2% | 20 |
3 | BACTERIAL PNEUMONIA | 12 | 12% | 8% | 93 |
4 | PERSISTENT GENERALIZED LYMPHADENOPATHY | 7 | 31% | 2% | 18 |
5 | SPLIT VIRION | 5 | 32% | 1% | 13 |
6 | HYPERGAMMAGLOBULINEMIA | 5 | 33% | 1% | 12 |
7 | PROTECTIVE ANTIBODY | 5 | 55% | 1% | 6 |
8 | HIV 1 INFECTED UGANDAN ADULTS | 4 | 38% | 1% | 8 |
9 | RUBELLA REVACCINATION | 3 | 100% | 0% | 3 |
10 | MEASLES ANTIBODY | 3 | 42% | 0% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
B cells in HIV infection and disease | 2009 | 229 | 114 | 35% |
The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review | 2011 | 25 | 43 | 84% |
Pandemic H1N1(2009) influenza and HIV: a review of natural history, management and vaccine immunogenicity | 2012 | 9 | 32 | 72% |
Guidance on vaccination of HIV-infected children in Europe | 2012 | 15 | 74 | 49% |
HIV and pneumococcal disease | 2007 | 43 | 25 | 56% |
Global strategies to prevent bacterial pneumonia in adults with HIV disease | 2004 | 73 | 116 | 65% |
Pulmonary infections in HIV-infected patients: an update in the 21st century | 2012 | 18 | 135 | 33% |
Do children infected with HIV receiving HAART need to be revaccinated? | 2010 | 30 | 54 | 61% |
Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis | 2008 | 51 | 13 | 54% |
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease | 2008 | 48 | 131 | 55% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MALAWI LIVERPOOL WELLCOME PROGRAMME CLIN TROP | 3 | 60% | 0.3% | 3 |
2 | DPUO | 3 | 32% | 0.6% | 7 |
3 | UNIT IMMUNE INFECT DIS | 2 | 40% | 0.3% | 4 |
4 | OSPED CIVILE NUOVO | 1 | 100% | 0.2% | 2 |
5 | PATHOL IMMUNOL PAEDIAT | 1 | 100% | 0.2% | 2 |
6 | INFECT DIS C5P | 1 | 33% | 0.3% | 3 |
7 | SWISS INFLUENZA | 1 | 40% | 0.2% | 2 |
8 | ACIP ADULT IMMUNIZAT WORKING GRP | 1 | 50% | 0.1% | 1 |
9 | CIC VACCINOL COCHIN PASTEURINSERMCIC BT505 | 1 | 50% | 0.1% | 1 |
10 | CICBT505 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |